Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein

被引:0
|
作者
机构
来源
Proc Natl Acad Sci USA | / 2卷 / 631期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] MONOCLONAL-ANTIBODIES TO IMMUNODOMINANT AND NEUTRALIZING DOMAINS OF THE ENVELOPE SURFACE PROTEIN OF FELINE IMMUNODEFICIENCY VIRUS
    EGBERINK, H
    KELDERMANS, L
    SCHUURMAN, N
    STAM, J
    HESSELINK, W
    VANVLIET, A
    VERSCHOOR, E
    HORZINEK, M
    DERONDE, A
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 889 - 893
  • [32] Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies
    Louie, Raymond H. Y.
    Kaczorowski, Kevin J.
    Barton, John P.
    Chakraborty, Arup K.
    McKay, Matthew R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (04) : E564 - E573
  • [33] Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein
    Earl, PL
    Broder, CC
    Doms, RW
    Moss, B
    JOURNAL OF VIROLOGY, 1997, 71 (04) : 2674 - 2684
  • [34] Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope
    VanCott, TC
    Mascola, JR
    Loomis-Price, LD
    Sinangil, F
    Zitomersky, N
    McNeil, J
    Robb, ML
    Birx, DL
    Barnett, S
    JOURNAL OF VIROLOGY, 1999, 73 (06) : 4640 - 4650
  • [35] HUMAN-IMMUNODEFICIENCY-VIRUS NEUTRALIZING ANTIBODIES RECOGNIZE SEVERAL CONSERVED DOMAINS ON THE ENVELOPE GLYCOPROTEINS
    HO, DD
    SARNGADHARAN, MG
    HIRSCH, MS
    SCHOOLEY, RT
    ROTA, TR
    KENNEDY, RC
    CHANH, TC
    SATO, VL
    JOURNAL OF VIROLOGY, 1987, 61 (06) : 2024 - 2028
  • [36] Successfull induction of antibodies with neutralizing properties directed at hepatitis C virus envelope protein E2 following DNA immunization
    Fournillier, A
    Depla, E
    Karayiannis, P
    Vidalin, O
    Maertens, G
    Trepo, C
    Inchauspe, G
    HEPATOLOGY, 1999, 30 (04) : 451A - 451A
  • [37] IMMUNOGENICITY OF RECOMBINANT INFLUENZA-VIRUS HEMAGGLUTININ CARRYING PEPTIDES FROM THE ENVELOPE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    KALYAN, NK
    LEE, SG
    WILHELM, J
    PISANO, MR
    HUM, WT
    HSIAO, CL
    DAVIS, AR
    EICHBERG, JW
    ROBERTGUROFF, M
    HUNG, PP
    VACCINE, 1994, 12 (08) : 753 - 760
  • [38] AN INFECTIOUS CHIMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) EXPRESSING THE HIV-1 PRINCIPAL NEUTRALIZING DETERMINANT
    MAMOUNAS, M
    LOONEY, DJ
    TALBOTT, R
    WONGSTAAL, F
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6424 - 6429
  • [39] CONFRONTING THE HYPERVARIABILITY OF AN IMMUNODOMINANT EPITOPE ELICITING VIRUS NEUTRALIZING ANTIBODIES FROM THE ENVELOPE GLYCOPROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
    NEURATH, AR
    STRICK, N
    MOLECULAR IMMUNOLOGY, 1990, 27 (06) : 539 - 549
  • [40] Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen
    McElrath, MJ
    Corey, L
    Greenberg, PD
    Matthews, TJ
    Montefiori, DC
    Rowen, L
    Hood, L
    Mullins, JI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 3972 - 3977